New study aims to uncover why some heart infections turn deadly
NCT ID NCT03211975
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 645 patients hospitalized with infectious endocarditis, a serious heart infection. Researchers will track hospital deaths and long-term survival to identify factors that influence prognosis. The goal is to better understand how the disease progresses and what affects patient outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict outcomes and improve care for patients with infectious endocarditis.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOCARDITIS INFECTIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens Picardie
RECRUITINGAmiens, Picardie, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One or two infusions could replace weeks of antibiotics for heart infection
- 22,000 patients studied to unlock secrets of deadly heart infection
- Chest ultrasound may replace throat probe for heart infection diagnosis
- Pill power: oral antibiotics may match IVs for serious heart infection
- Heart infection registry aims to uncover clues for better care